首页> 美国卫生研究院文献>The Journal of Clinical Investigation >Reduced microvascular thrombosis and improved outcome in acute murine stroke by inhibiting GP IIb/IIIa receptor-mediated platelet aggregation.
【2h】

Reduced microvascular thrombosis and improved outcome in acute murine stroke by inhibiting GP IIb/IIIa receptor-mediated platelet aggregation.

机译:通过抑制GP IIb / IIIa受体介导的血小板凝集减少了微血管血栓形成并改善了急性鼠中风的预后。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Treatment options in acute stroke are limited by a dearth of safe and effective regimens for recanalization of an occluded cerebrovascular tributary, as well as by the fact that patients present only after the occlusive event is established. We hypothesized that even if the site of major arterial occlusion is recanalized after stroke, microvascular thrombosis continues to occur at distal sites, reducing postischemic flow and contributing to ongoing neuronal death. To test this hypothesis, and to show that microvascular thrombosis occurs as an ongoing, dynamic process after the onset of stroke, we tested the effects of a potent antiplatelet agent given both before and after the onset of middle cerebral arterial (MCA) occlusion in a murine model of stroke. After 45 min of MCA occlusion and 23 h of reperfusion, fibrin accumulates in the ipsilateral cerebral hemisphere, based upon immunoblotting, and localizes to microvascular lumena, based upon immunostaining. In concordance with these data, there is a nearly threefold increase in the ipsilateral accumulation of 111In-labeled platelets in mice subjected to stroke compared with mice not subjected to stroke. When a novel inhibitor of the glycoprotein IIb/IIIa receptor (SDZ GPI 562) was administered immediately before MCA occlusion, platelet accumulation was reduced 48%, and fibrin accumulation was reduced by 47% by immunoblot densitometry. GPI 562 exhibited a dose-dependent reduction of cerebral infarct volumes measured by triphenyltetrazolium chloride staining, as well as improvement in postischemic cerebral blood flow, measured by laser doppler. GPI 562 caused a dose-dependent increase in tail vein bleeding time, but intracerebral hemorrhage (ICH) was not significantly increased at therapeutic doses; however, there was an increase in ICH at the highest doses tested. When given immediately after withdrawal of the MCA occluding suture, GPI 562 was shown to reduce cerebral infarct volumes by 70%. These data support the hypothesis that in ischemic regions of brain, microvascular thrombi continue to accumulate even after recanalization of the MCA, contributing to postischemic hypoperfusion and ongoing neuronal damage.
机译:急性中风的治疗选择受限于缺乏对被阻塞的脑血管支流再通的安全有效方法,以及患者仅在发生阻塞事件后才出现的事实。我们假设即使卒中后主要动脉闭塞部位重新成形,远端部位仍会继续发生微血管血栓形成,从而减少缺血后血流并导致持续的神经元死亡。为了验证这一假设,并显示中风发作后微血管血栓形成是一个持续的动态过程,我们测试了在大脑中动脉阻塞之前和之后给予的有效抗血小板药的作用。小鼠中风模型。经过45分钟的MCA阻塞和23小时的再灌注后,基于免疫印迹,血纤维蛋白积聚在同侧脑半球中,基于免疫染色,血纤蛋白定位于微血管腔。根据这些数据,与未中风的小鼠相比,中风的小鼠的111In标记血小板的同侧累积增加了近三倍。在MCA闭塞前立即给予糖蛋白IIb / IIIa受体新型抑制剂(SDZ GPI 562)时,免疫印迹光密度法可将血小板积聚减少48%,将纤维蛋白积聚减少47%。 GPI 562通过三苯基氯化四氮唑染色显示出剂量依赖性的减少脑梗死体积,并通过激光多普勒测量出缺血后脑血流量的改善。 GPI 562引起尾静脉出血时间的剂量依赖性增加,但是在治疗剂量下脑出血(ICH)并未显着增加。但是,在测试的最高剂量下,ICH有所增加。当撤回MCA闭塞缝合线后立即给予GPI 562可减少70%的脑梗死体积。这些数据支持这样的假设,即即使在MCA再通后,在脑缺血区域,微血管血栓仍继续积聚,导致缺血后灌注不足和持续的神经元损伤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号